Thinking Seelos Blog

Fireside Chat Replay from B. Riley Securities’ Virtual Neuro and Ophthalmology Conference on 4/27/2022

Seelos Therapeutics, Inc. (Nasdaq: SEEL) Chairman and CEO, Raj Mehra, Ph.D., and Chief Medical Officer, Tim Whitaker, MD, participated in a fireside chat at B. Riley Securities’ Virtual Neuro and Ophthalmology Conference on Wednesday, April 27th at 12:00 PM ET. https://www.webcaster4.com/Webcast/Page/2875/45355

Fireside Chat Replay: Current Treatment of Acute Suicidal Ideation and Behavior and Discussion on the Market Potential for Seelos Therapeutics’ SLS-002 Program from 4/25/2022

The fireside chat featured Evan P. Cohen, MD (Montefiore St. Luke’s Cornwall in Newburgh, New York) and John Misdary, MD (Excelis Medical Associates in Tampa, FL), who discussed the stresses and associated healthcare costs psychiatric patients place on emergency department physicians and staff, specifically patients with Acute Suicidal Ideation and Behavior (ASIB). The discussion was…
Read more

Panel Replay from Maxim Group LLC and M-Vest’s Advances in Mental Health Virtual Conference on 9/22/2021

https://m-vest.com/insights/marketpulse/advances-in-mental-health-panel-replays

Archived webcast from Virtual Cantor Global Healthcare Conference 9/29/2021

https://wsw.com/webcast/cantor12/seel/2075290

Archived Webcast of Seelos Presentation of PoC, Open-Label Safety and Efficacy of SLS-002

Conference Call with Seelos Management and David V. Sheehan, M.D., Distinguished University Health Professor Emeritus at the University of South Florida College of Medicine, discussing the Proof-of-Concept open-label safety and efficacy data on May 17, 2021. https://public.viavid.com/index.php?id=144999

Dr. Raj Mehra Interview with CheckRare – Rare and Genetic Disease Network on Sanfilippo Syndrome

CheckRare interviewed Raj Mehra, PhD of Seelos Therapeutics on Sanfilippo Syndrome. Please follow this link for the archive of this interview: https://checkrare.com/sanfilippo-syndrome-2/

Dr. Raj Mehra Interview with Nicole Petallides of TD Ameritrade Network’s “The Watchlist”

Live from the Nasdaq market site, Nicole Petallides of TD Ameritrade Network’s “The Watchlist” interviewed Raj Mehra, PhD on Seelos Therapeutics’ pipeline developments and corporate highlights on March 25, 2019. Please follow this link for the archive of this interview: https://tdameritradenetwork.com/video/rB4AoWmoG5SBabX3gpQB8Q

Dr. Raj Mehra Interview with Proactive Investors

by Anthony Marciano On the morning of March 8, 2019 Dr. Raj Mehra was interviewed by Proactive Investors. Among the notable items in this video interview, Dr. Mehra shared how the company has acquired an exclusive license to the rights to a potential Parkinson’s disease therapy created by researchers at the University of California, Los…
Read more

Our Acquisition of a Disease-Modifying Parkinson’s Disease Therapy

by Anthony Marciano On March 07, 2019, Seelos Therapeutics, Inc. (Nasdaq: SEEL) announced it acquired an exclusive license to intellectual property owned by The Regents of the University of California (The UC Regents) pertaining to a technology that was created by researchers at the University of California, Los Angeles (UCLA). Such technology relates to a…
Read more